Development of a Chemiluminescence Immunoassay for Quantification of 25-Hydroxyvitamin D in Human Serum

Table 3

Distribution of clinical samples.

Conc. of 25(OH)D	Fracture	Osteoporosis	Osteoarthritis	Autoimmune diseases	Cancer	Diabetes	Cardiovascular disease
<30 ng/mL	41	25	55	140	203	524	53
>30 ng/mL	0	4	1	16	6	27	1
Total	41	29	56	156	209	551	54